Related Experiment Videos
Liver biopsy sampling in chronic viral hepatitis
1Università Degli Studi di Padova, Azienda Ospedale, Padova, Italy. mguido@unipd.it
Seminars in Liver Disease
|April 16, 2004
Summary
For chronic viral hepatitis, needle liver biopsies may not accurately represent liver damage. A sample of at least 2 cm with 11 portal tracts is recommended for reliable grading and staging.
Area of Science:
- Hepatology
- Pathology
- Medical Diagnostics
Background:
- Liver biopsy is crucial for assessing chronic viral hepatitis severity.
- Percutaneous needle biopsy provides a small tissue sample, raising representativeness concerns.
- Current methods have methodological limitations in evidence-based medicine.
Purpose of the Study:
- To evaluate the reliability of liver biopsy for grading and staging chronic viral hepatitis.
- To determine optimal criteria for a representative liver biopsy sample.
Main Methods:
- Critical review of existing literature on liver biopsy techniques and representativeness.
- Integration of historical and recent data on biopsy sample adequacy.
Main Results:
- Needle biopsy samples represent a very small fraction of liver mass, questioning their accuracy.
- A liver biopsy sample of 2 cm or longer, with at least 11 complete portal tracts, is proposed as reliable.
- This standard addresses methodological limits of current biopsy practices.
Conclusions:
- Standardizing liver biopsy sample size and content is essential for accurate chronic viral hepatitis assessment.
- A minimum sample length and portal tract count can enhance diagnostic reliability.
- Improved biopsy standards support evidence-based clinical decision-making in viral hepatitis management.